The Center
Multiple Sclerosis Center Dresden
Patient Information
Contact MSC
Physicians & Nurses
Study Team
Neuropsychology
Mobility Center
The Mobility Center
Walking Assessment
Jump Assessment
DIERS
EMIQ
Projects
Neuroimmunological Laboratory
The NIL
Neurofilament light chain
Autonomic & Neuroendocrinological Functional Laboratory
The ANF
ANF Assessment
MS Living Lab
Management & Science
Team Management & Science
Projects
eHealth & Analytics
MSDS 3D
MSDS Clinic & Practice
MS-HRS
MTRS
Multiple Sclerosis Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
English (UK)
Deutsch
English (UK)
Intensified monitoring of circadian blood pressure and heart rate before and after intravitreous injection of bevacizumab: preliminary findings of a pilot study
ANF
Jahr
Publikationsjahr
2009
Autoren
Autorenliste der Publikation
Ziemssen F, Zhu Q, Peters S, Grisanti S, El Wardani M, Szurman P, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group; Ziemssen T.
Verlag
Publisher-Information
Int Ophthalmol. 2009 Aug;29(4):213-24.
Link
Zur Publikation (externer Server)
https://doi.org/10.1007/s10792-008-9221-7
Tags
Forschungsthemen
Autonomes Nervensystem & Neuroendokrinologie
Herzratenvariabilität
Baroreflexsensitivität
Andere
Andere
ANF
BRS
HRV
2009
RENEWED: A follow-up study of the opicinumab phase 2 RENEW study in participants with acute optic neuritis
Other
Jahr
2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
MS Treatments
Jahr
2024
Neurological complications in oncology and their monitoring and management in clinical practice: a narrative review
Other
Jahr
2024
Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis
ANF
Jahr
2024
Serum neurofilament light chain as a sensitive biomarker for neuromonitoring during extracorporeal membrane oxygenation
NIL
Jahr
2024